Virtus Biotech Clinical Trials ETF (BBC)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn morePerformance Overview
Trailing returns as of 11/6/2026. Category is Health.
YTD Return
1-Year Return
3-Year Return
Trailing Returns (%) Vs. Benchmarks
- YTD
- 11.22%
- -2.39%
- 1-Month
- -6.76%
- 1.70%
- 3-Month
- -11.90%
- -3.03%
- 1-Year
- 35.43%
- 21.31%
- 3-Year
- 35.40%
- 6.58%
- 5-Year
- -0.02%
- 1.49%
- 10-Year
- 9.52%
- 8.56%
- Last Bull Market
- 0.00%
- 0.00%
- Last Bear Market
- 0.00%
- 0.00%
Annual Total Return (%) History
ETF Summary
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
ETF Overview
| Category | Health |
|---|---|
| Fund Family | Virtus |
| Net Assets | 34.42M |
| YTD Daily Total Return | 11.57% |
| Yield | 1.52% |
| Legal Type | Exchange Traded Fund |
